NCT00243698View on ClinicalTrials.gov

A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

May 31, 2007

Conditions
Breast Tumors
Interventions
DRUG

SonoVue (sulphur hexafluoride microbubbles)

One contrast enhanced ultrasonography using sonovue / 4.8 ml per injection (maximum of 3 injections)

Trial Locations (1)

37044

University Hospital of Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT00243698 - A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions | Biotech Hunter | Biotech Hunter